InvestorsHub Logo

north40000

11/29/19 12:49 PM

#332391 RE: biopharm #332389

Anent your post, Dr. Wolchok said, as we know "..depends on the company.."
Also depends on results in ongoing human clinical trials.

GILD/KITE, and those 11th and twelfth cohorts? NVS? MRK now has an ongoing trial in colon cancer.